Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Urology therapeutics Market Research Reports

Titlepublishedprice

Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ive of the Interstitial Cystitis (Painful Bladder Syndrome) Report is to understand the market and pipeline status of the drugs around the Interstitial Cystitis (Painful Bladder Syndrome) to explore the generic development opportunities, licensing op......"
01-Jan-2017$2000

Interstitial Cystitis  - Epidemiology Forecast To 2023

By Delve Insight
"...... Cystitis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Interstitial Cystitis . The repo......"
01-Jan-2017$2750

Bladder Pain-Pipeline Insights, 2017

By Delve Insight
"...... ase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations detail......"
01-Jan-2017$1250

Interstitial Cystitis-Pipeline Insights, 2017

By Delve Insight
"...... -clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA d......"
01-Jan-2017$1250

Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2017

By Delve Insight
"...... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborat......"
01-Jan-2017$1250

Urethritis-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Urinary Incontinence-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Nocturnal Enuresis - Epidemiology Forecast To 2023

By Delve Insight
"...... evalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Nocturnal Enuresis. The report is built usin......"
01-Jan-2017$2750

Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... t covers the therapeutics market revenue; average cost of therapy, treatment practice and Urinary Incontinence forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of ep......"
01-Jan-2017$4950

Overactive Bladder-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Overactive Bladder to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveI......"
01-Jan-2017$2000

Avail upto 50% Discount on below Publisher Reports.